Platelet aggregation and coagulation and fibrinolysis parameters in both portal and systemic circulations in patients with cirrhosis and hepatocellular carcinoma

Hepatology Research

Volumn 19, Issue 1, 2001, Pages 52-59

  Kunihiro, Naoko ^a   Kawai, Bunpei ^a   Sanjo, Akira ^a   Osaka, Kazuhiro ^a   Ohnishi, Akihiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coagulation; Fibrinolysis; Liver cirrhosis; Platelet aggregation; Prostaglandin

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM ION; COLLAGEN; FIBRINOGEN DEGRADATION PRODUCT; PROSTACYCLIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; FOREARM; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SYSTEMIC CIRCULATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; VENOUS BLOOD;

EID: 0035191294     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00078-4     Document Type: Article

References (22)

1. Platelet adhesiveness to glass beads in liver disease
2. Platelet aggregation in patients with Lannec's cirrhosis of the liver
3. Platelet aggregation in portal cirrhosis
4. Platelet lipid composition and platelet aggregation in human liver disease
5. Altered platelet function in cirrhosis of the liver: Impairment of inositol lipid and arachidonic acid metabolism in response to agonists
6. Platelet thromboxane formation capacity after ethanol withdrawal in chronic alcoholism
7. Platelet thromboxane production in liver cirrhosis
8. Prostaglandin production in cirrhosis and portal hypertention - Experimental and clinical study
9. Aggregation of blood platelets by adenosine diphosphate and its reversal
10. A new method for the determination of fibrinogen in small samples of plasma
11. A rapid, simple, sensitive method of measuring fibrinolytic split products human serum
12. Methods for the evaluation of human fibrinolysis: Studies with two combined technics
13. Mechanisms of platelet aggregation
14. Stimulation of protein phosphorylation by arachidonic acid and endoperoxide analog
15. Thromboxane-induced phosphatidate formation in human platelets
16. Effects of epoxymethano analogues of prostagrandin endoperoxides on aggregation on release of 5-hydroxytryptamine and on the metabolism of 3′5′-cyclic AMP and cyclic GMP in human platelets
17. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin
18. Synergism between platelet-aggregating agents: The role of arachidonic pathway
19. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: A critical role for tissue plasminogen activator inhibitor
20. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis
21. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not
22. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets